NBC Nightly News (12/8, story 7, 2:20, Williams) reported, “Medical experts have been taking…[a] look at Drospirenone/Ethinyl Estradiol [Yaz], because of studies that show they may be more likely to cause dangerous blood clots than older versions of the” medication. Chief Medical Editor Dr. Nancy Snyderman said, “Two of the most popular birth control” medications “in use — Yaz and Yasmin — were the focus of FDA hearings today about their safety. The majority of the expert panel this evening voted that the labels both for Yaz and Yasmin should have tighter revisions, but not clear yet what those revisions will be.”
Author: Sarah Showardhttp://showardlaw.com
Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Women's Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorney, and has been representing plaintiffs since 1990.